Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARMONY CTP: Pitolisant for Cataplexy in Narcolepsy
NCT01800045Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Apr 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Narcolepsy type 1 (NT1) comparing Pitolisant with Placebo (2 arms). Primary endpoint: Change in Weekly Frequency of Cataplexy Attacks at 7 weeks. Started Apr 2013; status: completed.
02
Drugs
pitolisant
03
Conditions
Narcolepsy type 1 (NT1)
Beyond the preview
Go deeper on NCT01800045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01800045.